Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.840
+0.050 (2.79%)
At close: Apr 28, 2026, 4:00 PM EDT
1.830
-0.010 (-0.54%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$1,704,846
Market Cap
331.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Nautilus Biotechnology | 130 |
| Rezolute | 75 |
| Armata Pharmaceuticals | 60 |
| Immuneering | 53 |
| Surrozen | 44 |
| DiaMedica Therapeutics | 35 |
| Inhibikase Therapeutics | 35 |
CMPX News
- 1 day ago - Compass Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 1 day ago - Compass Therapeutics Drops Sharply As Trial Crossover Complicates Survival Data In Bile Duct Cancer Patients - Benzinga
- 1 day ago - Compass Therapeutics Transcript: Study update - Transcripts
- 1 day ago - Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer - GlobeNewsWire
- 4 days ago - Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer - GlobeNewsWire
- 7 weeks ago - Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Compass Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 4 months ago - Compass Therapeutics Provides Corporate Update - GlobeNewsWire